144 related articles for article (PubMed ID: 2543084)
1. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
2. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
Snyder HW; Singhal MC; Hardy WD; Jones FR
J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
[TBL] [Abstract][Full Text] [Related]
3. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
Jones FR; Grant CK; Snyder HW
J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats.
Day NK; O'Reilly-Felice C; Hardy WD; Good RA; Witkin SS
J Immunol; 1980 Dec; 125(6):2363-6. PubMed ID: 6253567
[TBL] [Abstract][Full Text] [Related]
5. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
Engelman RW; Good RA; Day NK
Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.
Snyder HW; Jones FR; Day NK; Hardy WD
J Immunol; 1982 Jun; 128(6):2726-30. PubMed ID: 6281336
[TBL] [Abstract][Full Text] [Related]
7. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
8. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
9. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract][Full Text] [Related]
10. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat.
Cotter SM; Hardy WD; Essex M
J Am Vet Med Assoc; 1975 Mar; 166(5):449-54. PubMed ID: 163223
[TBL] [Abstract][Full Text] [Related]
11. Natural immunity in cats to feline leukemia viral antigens.
Ruscetti SK; Parks WP
J Immunol; 1976 Nov; 117(5 Pt.2):2029-35. PubMed ID: 186536
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
[TBL] [Abstract][Full Text] [Related]
13. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
14. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
Lafrado LJ; Mathes LE; Zack PM; Olsen RG
Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
[TBL] [Abstract][Full Text] [Related]
15. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma.
Harper HD; Sjöquist J; Hardy WD; Jones FR
Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866
[TBL] [Abstract][Full Text] [Related]
17. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia.
Liu WT; Engelman RW; Trang LQ; Hau K; Good RA; Day NK
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3516-20. PubMed ID: 6328520
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
19. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
20. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
